FB
NVO

Fulton Bank’s Novo Nordisk NVO Stock Holding History

Fulton Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+4,672
New +$201K 0.01% 658
2026
Q1 		– Sell
-9,045
Closed -$460K – 676
2025
Q4 		$460K Buy
9,045
+964
+12% +$49.3K 0.02% 469
2025
Q3 		$448K Buy
8,081
+4,972
+160% +$291K 0.02% 462
2025
Q2 		$215K Buy
+3,109
New +$211K 0.01% 634
2024
Q4 		– Sell
-1,817
Closed -$216K – 687
2024
Q3 		$216K Sell
1,817
-949
-34% -$127K 0.01% 622
2024
Q2 		$395K Sell
2,766
-1,950
-41% -$258K 0.02% 446
2024
Q1 		$606K Sell
4,716
-28
-0.6% -$3.33K 0.02% 354
2023
Q4 		$491K Buy
4,744
+996
+27% +$98.5K 0.02% 372
2023
Q3 		$341K Sell
3,748
-1,282
-25% -$113K 0.02% 425
2023
Q2 		$407K Buy
+5,030
New +$411K 0.02% 371
2019
Q2 		– Sell
-7,676
Closed -$201K – 430
2019
Q1 		$201K Buy
+7,676
New +$189K 0.01% 404

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fulton Bank's NVO Position: Q2 2026 in Review

Fulton Bank opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,672 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #658 among its holdings. This is a return to the name: Fulton Bank previously reported a position in NVO as recently as Q4 2025.

Fulton Bank first reported a position in NVO in Q1 2019 and has held it in 11 quarters since. The position peaked at $606K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Fulton Bank held 4,672 shares of Novo Nordisk worth $224K as of Q2 2026.
  • Novo Nordisk was a new Fulton Bank position in Q2 2026.
  • Novo Nordisk made up 0.01% of Fulton Bank's portfolio in Q2 2026, its #658 holding.
  • Fulton Bank first reported a position in Novo Nordisk in Q1 2019 and has held it in 11 quarters since.
  • Fulton Bank's Novo Nordisk position peaked at $606K in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.